Nucleic Acid Therapeutics Global Market Report 2026

Description

Nucleic acid therapeutics are a class of treatments that use nucleic acids, including deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or their synthetic analogues, to modulate gene expression or correct genetic mutations, enabling disease treatment at the molecular level. These therapies employ synthetic DNA or RNA strands to precisely target and regulate specific genetic sequences, offering solutions for diseases that are difficult to address with conventional drugs.

The main therapy types of nucleic acid therapeutics include antisense oligonucleotides (ASOs), small interfering RNA (siRNA), gene therapies, aptamers, and others. Antisense oligonucleotides (ASOs) are short, synthetic nucleic acid strands that bind to specific messenger RNA (mRNA) molecules to block or modify the expression of target genes. Nucleic acid therapeutics are applied across multiple therapeutic areas, including neuromuscular disorders, metabolic disorders, cardiovascular diseases, ophthalmological disorders, and oncology. They are administered through various routes such as intravenous and subcutaneous injections and utilize different delivery methods, including viral vector-based and non-viral systems. Key end users of these therapies include pharmaceutical companies, biotechnology firms, and government and academic research institutions.

Tariffs have affected the nucleic acid therapeutics market by increasing the cost of imported raw materials, viral vectors, lipid nanoparticles, and advanced synthesis reagents. Segments such as gene therapies and RNA-based therapeutics are most impacted, particularly in regions like North America and Europe, which rely heavily on imports from Asia-Pacific. While tariffs have increased operational costs and slowed supply chains, they have also encouraged domestic manufacturing, investment in local R&D, and innovation in cost-effective delivery systems.

The nucleic acid therapeutics market research report is one of a series of new reports from The Business Research Company that provides nucleic acid therapeutics market statistics, including nucleic acid therapeutics industry global market size, regional shares, competitors with a nucleic acid therapeutics market share, detailed nucleic acid therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid therapeutics industry. This nucleic acid therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid therapeutics market size has grown rapidly in recent years. It will grow from $6.94 billion in 2025 to $8.01 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to limited availability of nucleic acid therapeutics, reliance on traditional small molecule therapies, growing demand for precision medicine, regulatory approvals for early gene therapies, increasing academic research on gene modulation.

The nucleic acid therapeutics market size is expected to see rapid growth in the next few years. It will grow to $14.07 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to development of crispr and other gene editing technologies, expansion of lipid nanoparticle (lnp) delivery systems, rising adoption of personalized nucleic acid therapies, increasing collaborations between pharma and biotech, growing investment in rna-based therapeutics. Major trends in the forecast period include rising adoption of antisense oligonucleotides (asos) and sirna therapies, expansion of crispr-based and gene editing therapeutics, growth in targeted therapies for neuromuscular, metabolic, and oncological disorders, increasing investment in non-viral and viral delivery systems, emergence of long non-coding rna (lncrna) and microrna (mirna) therapeutics.

The mounting prevalence of genetic and chronic diseases is poised to drive the nucleic acid therapeutics market forward. Genetic and chronic diseases encompass the interplay between hereditary genetic elements and the onset, advancement, or susceptibility to enduring ailments like diabetes, heart conditions, cancer, and autoimmune issues. This escalation mainly results from enhanced diagnostic tools that detect these disorders more precisely and promptly. Nucleic acid therapeutics prove valuable for genetic and chronic diseases by addressing root genetic drivers-through gene regulation, correction, or suppression-delivering targeted, individualized care. For instance, in October 2024, the Cystic Fibrosis Trust, a UK charity aiding cystic fibrosis patients, reported 11,148 registered cases in 2022, rising to 11,318 in 2023-a 1.5% year-on-year jump in registrations. Thus, the growing burden of genetic and chronic diseases is spurring the nucleic acid therapeutics market.

Prominent firms in the nucleic acid therapeutics market are advancing novel solutions like antisense oligonucleotide therapy to pinpoint and mute disease-linked genes, providing exact treatments for genetic and rare conditions. Antisense oligonucleotide therapy employs brief, lab-made DNA or RNA strands to inhibit or alter expression of disease-related genes. For example, in December 2024, Ionis Pharmaceuticals Inc., a US biotech company, secured FDA approval for TRYNGOLZ (olezarsen) as a dietary adjunct to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), a rare genetic condition marked by extreme hypertriglyceridemia (sHTG) and elevated acute pancreatitis (AP) risk. It marks the inaugural FDA-endorsed option for substantial, lasting triglyceride drops in this group, plus notable AP reductions paired with a low-fat diet. The treatment supports easy monthly self-injection via auto-injector.

In June 2025, Novartis AG, a Switzerland-based innovator in drug development and production, acquired Regulus Therapeutics Inc. for an undisclosed sum. This deal seeks to fortify Novartis's RNA-targeted drug expertise, enrich its portfolio for rare and chronic diseases, and hasten next-gen therapies leveraging Regulus's microRNA prowess. Regulus Therapeutics Inc. is a US biotech firm dedicated to microRNA-based therapies.

Major companies operating in the nucleic acid therapeutics market are Pfizer Inc., Novartis AG, Moderna Inc., BioNTech SE, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., CureVac SE, Sangamo Therapeutics Inc., Beam Therapeutics Inc., Arbutus Biopharma Corporation, Silence Therapeutics plc, Copernicus Therapeutics Inc.

North America was the largest region in the nucleic acid therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nucleic acid therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nucleic acid therapeutics market consists of revenues earned by entities by providing services such as custom oligonucleotide synthesis, gene silencing and editing services, drug discovery and development support, messenger RNA (mRNA) and small interfering RNA (siRNA) design and optimization, and delivery system development. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid therapeutics market also includes sales of messenger RNA (mRNA) therapeutics, clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing tools (therapeutic use), aptamers, and Amondys 45 (casimersen). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nucleic Acid Therapeutics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses nucleic acid therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nucleic acid therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nucleic acid therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Therapy Type: Antisense Oligonucleotides (ASOs); Small Interfering RNA (siRNA); Gene Therapies; Aptamers; Other Therapy Types
2) By Therapeutic Area: Neuromuscular Disorder; Metabolic Disorders; Cardiovascular Disorders; Ophthalmological Disorders; Oncological Disorders; Other Therapeutic Areas
3) By Route Of Administration: Intravenous; Subcutaneous; Other Route Of Administrations
4) By Delivery Method: Viral Vector-Based Delivery Systems; Non-Viral Delivery Systems
5) By End-Use: Pharmaceutical Companies; Government And Academic Research Institutes; Biotech Companies
Subsegments:
1) By Antisense Oligonucleotides (ASOs): Phosphorothioate ASOs; 2'-O-Methyl ASOs; Locked Nucleic Acid (LNA) ASOs; Gapmer ASOs; Morpholino ASOs
2) By Small Interfering RNA (siRNA): Lipid Nanoparticle (LNP) Formulated siRNA; GalNAc-Conjugated siRNA; Chemically Modified siRNA; Naked siRNA
3) By Gene Therapies: Viral Vector-Based Gene Therapy; Non-Viral Vector-Based Gene Therapy; CRISPR-Based Gene Therapy; Zinc Finger Nucleases (ZFNs); TALENs
4) By Aptamers: Ribonucleic Acid (RNA) Aptamers; Deoxyribonucleic Acid (DNA) Aptamers; Spiegelmers; Pegylated Aptamers
5) By Others Therapy Types: MicroRNA (miRNA) Therapeutics; Long Non-Coding RNA (lncRNA) Therapeutics; Ribonucleic Acid (RNA) Editing Therapies; Ribozymes
Companies Mentioned: Pfizer Inc.; Novartis AG; Moderna Inc.; BioNTech SE; Alnylam Pharmaceuticals Inc.; Sarepta Therapeutics Inc.; Arrowhead Pharmaceuticals Inc.; Arcturus Therapeutics Holdings Inc.; CureVac SE; Sangamo Therapeutics Inc.; Beam Therapeutics Inc.; Arbutus Biopharma Corporation; Silence Therapeutics plc; Copernicus Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH5MNATC01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Nucleic Acid Therapeutics Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Nucleic Acid Therapeutics Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Nucleic Acid Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Nucleic Acid Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Artificial Intelligence & Autonomous Intelligence
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Rising Adoption Of Antisense Oligonucleotides (Asos) And Sirna Therapies
- 4.2.2 Expansion Of Crispr-Based And Gene Editing Therapeutics
- 4.2.3 Growth In Targeted Therapies For Neuromuscular, Metabolic, And Oncological Disorders
- 4.2.4 Increasing Investment In Non-Viral And Viral Delivery Systems
- 4.2.5 Emergence Of Long Non-Coding Rna (Lncrna) And Microrna (Mirna) Therapeutics

5. Nucleic Acid Therapeutics Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies
5.2 Biotech Companies
5.3 Government And Academic Research Institutes
5.4 Clinical Research Organizations (Cros)
5.5 Hospitals And Specialty Treatment Centers

6. Nucleic Acid Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nucleic Acid Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Nucleic Acid Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Nucleic Acid Therapeutics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Nucleic Acid Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Nucleic Acid Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nucleic Acid Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nucleic Acid Therapeutics Market Segmentation

9.1. Global Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Gene Therapies, Aptamers, Other Therapy Types
9.2. Global Nucleic Acid Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Neuromuscular Disorder, Metabolic Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Oncological Disorders, Other Therapeutic Areas
9.3. Global Nucleic Acid Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Intravenous, Subcutaneous, Other Route Of Administrations
9.4. Global Nucleic Acid Therapeutics Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Viral Vector-Based Delivery Systems, Non-Viral Delivery Systems
9.5. Global Nucleic Acid Therapeutics Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical Companies, Government And Academic Research Institutes, Biotech Companies
9.6. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Antisense Oligonucleotides (ASOs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Phosphorothioate ASOs, 2'-O-Methyl ASOs, Locked Nucleic Acid (LNA) ASOs, Gapmer ASOs, Morpholino ASOs
9.7. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Small Interfering RNA (siRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Lipid Nanoparticle (LNP) Formulated siRNA, GalNAc-Conjugated siRNA, Chemically Modified siRNA, Naked siRNA
9.8. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Gene Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, CRISPR-Based Gene Therapy, Zinc Finger Nucleases (ZFNs), TALENs
9.9. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Aptamers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Ribonucleic Acid (RNA) Aptamers, Deoxyribonucleic Acid (DNA) Aptamers, Spiegelmers, Pegylated Aptamers
9.10. Global Nucleic Acid Therapeutics Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
MicroRNA (miRNA) Therapeutics, Long Non-Coding RNA (lncRNA) Therapeutics, Ribonucleic Acid (RNA) Editing Therapies, Ribozymes

10. Nucleic Acid Therapeutics Market Regional And Country Analysis

10.1. Global Nucleic Acid Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Nucleic Acid Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nucleic Acid Therapeutics Market

11.1. Asia-Pacific Nucleic Acid Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nucleic Acid Therapeutics Market

12.1. China Nucleic Acid Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nucleic Acid Therapeutics Market

13.1. India Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nucleic Acid Therapeutics Market

14.1. Japan Nucleic Acid Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nucleic Acid Therapeutics Market

15.1. Australia Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nucleic Acid Therapeutics Market

16.1. Indonesia Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nucleic Acid Therapeutics Market

17.1. South Korea Nucleic Acid Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nucleic Acid Therapeutics Market

18.1. Taiwan Nucleic Acid Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nucleic Acid Therapeutics Market

19.1. South East Asia Nucleic Acid Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nucleic Acid Therapeutics Market

20.1. Western Europe Nucleic Acid Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nucleic Acid Therapeutics Market

21.1. UK Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nucleic Acid Therapeutics Market

22.1. Germany Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nucleic Acid Therapeutics Market

23.1. France Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nucleic Acid Therapeutics Market

24.1. Italy Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nucleic Acid Therapeutics Market

25.1. Spain Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nucleic Acid Therapeutics Market

26.1. Eastern Europe Nucleic Acid Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nucleic Acid Therapeutics Market

27.1. Russia Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nucleic Acid Therapeutics Market

28.1. North America Nucleic Acid Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nucleic Acid Therapeutics Market

29.1. USA Nucleic Acid Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nucleic Acid Therapeutics Market

30.1. Canada Nucleic Acid Therapeutics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nucleic Acid Therapeutics Market

31.1. South America Nucleic Acid Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nucleic Acid Therapeutics Market

32.1. Brazil Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nucleic Acid Therapeutics Market

33.1. Middle East Nucleic Acid Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nucleic Acid Therapeutics Market

34.1. Africa Nucleic Acid Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Nucleic Acid Therapeutics Market, Segmentation By Therapy Type, Segmentation By Therapeutic Area, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nucleic Acid Therapeutics Market Regulatory and Investment Landscape

36. Nucleic Acid Therapeutics Market Competitive Landscape And Company Profiles

36.1. Nucleic Acid Therapeutics Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Nucleic Acid Therapeutics Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Nucleic Acid Therapeutics Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Alnylam Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Nucleic Acid Therapeutics Market Other Major And Innovative Companies

Sarepta Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., CureVac SE, Sangamo Therapeutics Inc., Beam Therapeutics Inc., Arbutus Biopharma Corporation, Silence Therapeutics plc, Copernicus Therapeutics Inc.

38. Global Nucleic Acid Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nucleic Acid Therapeutics Market

40. Nucleic Acid Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Nucleic Acid Therapeutics Market In 2030 - Countries Offering Most New Opportunities
40.2 Nucleic Acid Therapeutics Market In 2030 - Segments Offering Most New Opportunities
40.3 Nucleic Acid Therapeutics Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer